Other NIH Programs in South Carolina
National Institutes of Health Industrial Development Awards (IDeA) Funded Programs
Established by Congressional mandate in 1993, the IDeA Program builds research capacities in states that historically have had low levels of NIH funding by supporting basic, clinical, and translational research; faculty development; and infrastructure improvements. The program also enhances the ability of investigators to compete successfully for additional research funding and serves the research needs of medically underserved communities.
Shaded are the 23 states and Puerto Rico eligible for IDeA funding.
The IDeA program has five main components:
- Centers of Biomedical Research Excellence (COBRE) augment and strengthen institutional biomedical research capabilities by expanding and developing biomedical faculty research capability through support of a multidisciplinary center led by a peer-reviewed, NIH-funded investigator with expertise central to the theme of the grant proposal.
- IDeA Networks of Biomedical Research Excellence (INBRE) enhance biomedical research capacity, expand, and strengthen the research capabilities of biomedical faculty, and provide access to biomedical resources for promising undergraduate students throughout the eligible states. INBRE puts the IDeA approach into action by enhancing research infrastructure through support of a statewide research development network that links research-intensive institutions with primarily undergraduate institutions.
- IDeA Program Infrastructure for Clinical and Translational Research (IDeA-CTR) provides support for: 1) the development of infrastructure and human resources required to conduct clinical and translational research in IDeA-eligible states, 2) enhancing the ability of IDeA institutions and investigators to develop competitive clinical and translational research programs, 3) fostering and sustaining collaboration and coordination of clinical and translational activities within and across IDeA institutions/ organizations, and 4) addressing health conditions that affect the medically underserved and/or that are prevalent among populations in IDeA states.
- IDeA Co-funding provides support to NIH investigator-initiated R01 or R15 applications that received excellent ratings through the peer review process, but fell beyond an Institute’s or Center’s (ICs) pay line. NIH ICs select and submit eligible applications to NIGMS for consideration for IDeA Co-funding support, and maintain the administration and management of the applications that receive IDeA Co-funding.
- The STTR Regional Technology Transfer Accelerator Hubs for IDeA States program at the Division for Research Capacity Building supports the commercialization of innovative technologies and methodologies developed at IDeA states. A collaborative endeavor, the accelerator hubs would act as regional consortia to provide infrastructure and build an entrepreneurial culture at the IDeA institutions in that region. The goal of the program is to promote entrepreneurship, technology transfer, management, small business finance, and other skills needed to move discoveries and technologies out of the lab and into commercial products that address human health.
South Carolina’s IDeA Networks of Biomedical Research Excellence (INBRE)
This is our Program. In INBRE Cycle III (2015-2020), we are a network of 13 member and four outreach institutions located throughout our state. With our renewal, we will increase to 14 member institutions.
South Carolina’s Centers of Biomedical Research Excellence (COBRE) Programs
- Bioengineering Center of Regeneration and Formation of Tissues (SC BioCRAFT), Clemson University, Dr. Naren Vyavahare, Director
- Center for Dietary Supplements and Inflammation, UofSC School of Medicine, Drs. Mitzi Nagarkatti and Prakash Nagarkatti, Co-Directors
- Center for Targeted Therapeutics, University of South Carolina, Dr. Igor Roninson, Director
- COBRE: Eukaryotic Pathogens Innovation Center (EPIC), Clemson University, Dr. Lesly Temesvari, PI
- COBRE in Lipidomics and Pathobiology, Medical University of South Carolina, Dr. Besim Ogretmen, Director
- South Carolina COBRE for Developmentally Based Cardiovascular Diseases, Medical University of South Carolina, Dr. Roger Markwald, Director
- South Carolina COBRE in Oxidants, Redox Balance, and Stress Signaling, Medical University of South Carolina, Dr. Ken Tew, PI
- South Carolina Research Center for Recovery from Stroke, Medical University of South Carolina, Dr. Steve Kautz, Director
The IDeA States Pediatric Clinical Trials Network’s (ISPCTN) overarching goals are to provide access to state-of-the-art clinical trials to medically underserved and rural populations in the five ECHO priority areas of upper and lower airway disease, obesity, pre-, peri-, and postnatal outcomes, neurodevelopment, and overall positive health. The network will also build national pediatric research capacity to conduct clinical trials by providing professional development for faculty, team support and infrastructure building. In South Carolina, the Network is represented by TRANSFORM SC.
Other NIH Funded Programs in South Carolina
South Carolina Clinical & Translational Research Institute (SCTR) is a statewide NIH-funded Clinical and Translational Science Award (CTSA) Program Hub based at MUSC. It facilitates the sharing of resources and expertise and streamlines research-related processes to bring about large-scale change in the state’s clinical and translational research efforts. SCTR’s partners include the Medical University of South Carolina (MUSC), Clemson University, Health Sciences South Carolina, and the University of South Carolina. Their vision is to improve health outcomes and quality of life for South Carolinians by translating scientific discoveries into evidence-based clinical practice.